Although the statistical power was limited for subanalyses of the RF or ACPA-negative patients in the present study, crude estimates on the impact of overweight/obesity in these subsets were similar to seropositive patients. The gene discussed is PRTN3; the disease is obesity due to melanocortin 4 receptor deficiency.